XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows from Operating Activities:    
Net loss $ (20,741) $ (18,484)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 4,661 4,549
Amortization of costs capitalized to obtain contracts 663 864
Amortization of operating lease right-of-use asset 163 460
Stock-based compensation expense, net of amounts capitalized 19,047 18,224
Compensation expense in connection with revesting notes 0 73
Non-cash interest expense, net 59 295
Convertible notes fair value adjustment 608 194
Derivative liability fair value adjustment 1,707 240
Loss on settlement of convertible notes 440 0
Gain on settlement of derivative liability (1,924) 0
Non-cash revenue from investment (891) (993)
Inventory write-off 0 916
Adjustment in connection with membership benefit 0 (2,094)
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net 1,554 (343)
Prepaid expenses and other assets 6,024 (932)
Inventory (1,446) (480)
Costs capitalized to obtain contracts, net (785) (994)
Accounts payable 4,135 (6,680)
Accrued expenses and other current liabilities (783) (1,356)
Deferred revenue 1,512 1,055
Other liabilities, noncurrent (63) (42)
Net cash provided by (used in) operating activities 13,940 (5,528)
Cash Flows from Investing Activities:    
Internal use software (2,272) (865)
Purchase of property and equipment (51) (26)
Net cash used in investing activities (2,323) (891)
Cash Flows from Financing Activities:    
Indemnity escrow payment in connection with an acquisition 0 (13,128)
Proceeds from the exercise of stock options and warrants 4,461 1,569
Taxes paid related to net settlement of equity awards (15,944) (8,551)
Proceeds from issuance of common stock in U.S. initial public offering, net of underwriting discounts and commissions 93,000 0
Payments of U.S. initial public offering issuance costs (1,837) 0
Proceeds from repayment of notes due from affiliates 0 314
Net cash provided by (used in) financing activities 79,680 (19,796)
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash 91,297 (26,215)
Cash, Cash Equivalents and Restricted Cash at the Beginning of the Period 70,713 90,365
Cash, Cash Equivalents, and Restricted Cash at the End of the Period 162,010 64,150
Supplemental disclosure:    
Cash paid during the period for taxes 1,651 250
Cash paid during the period for interest 46 0
Non-cash investing and financing activities:    
Right of use asset recognized in connection with lease modification 0 1,054
Operating lease liability recognized in connection with lease modification 0 1,054
Property and equipment included within accrued expenses and other current liabilities 1,063 0
Stock-based compensation included in internal use software 373 0
IPO-related transaction costs included in accrued expenses and other current liabilities 4,455 0
Cash, cash equivalents and restricted cash    
Cash and cash equivalents 160,793 62,404
Restricted cash, noncurrent 1,217 1,746
Total cash and cash equivalents, and restricted cash 162,010 64,150
September 2021 Convertible Notes    
Non-cash investing and financing activities:    
Settlement of 2021 Convertible Notes to common stock and accrued interest 3,548 0
July 2021 Convertible Notes    
Non-cash investing and financing activities:    
Settlement of 2021 Convertible Notes to common stock and accrued interest $ 2,203 $ 0